Development of monoclonal antibodies and quantitative ELISAs targeting insulin-degrading enzyme

BACKGROUND: Insulin-degrading enzyme (IDE) is a widely studied zinc-metalloprotease implicated in the pathogenesis of type 2 diabetes mellitus, Alzheimer disease (AD) and varicella zoster virus infection. Despite more than six decades of research on IDE, progress has been hampered by the lack of wel...

Descripción completa

Detalles Bibliográficos
Autores principales: DelleDonne, Anthony, Kouri, Naomi, Reinstatler, Lael, Sahara, Tomoko, Li, Lilin, Zhao, Ji, Dickson, Dennis W, Ertekin-Taner, Nilufer, Leissring, Malcolm A
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2009
Materias:
Methodology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2768702/
https://www.ncbi.nlm.nih.gov/pubmed/19835587
http://dx.doi.org/10.1186/1750-1326-4-39

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2768702/
https://www.ncbi.nlm.nih.gov/pubmed/19835587
http://dx.doi.org/10.1186/1750-1326-4-39

Ejemplares similares